Skip to content

Clinical trials

Phase 2 Glioma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20112
20142
20171
20191
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals2
Actuate Therapeutics Inc.1
Clinica Universidad de Navarra, Universidad de Navarra1
Eli Lilly and Company1
Fore Biotherapeutics1
Hoffmann-La Roche1
Incyte Corporation1
Karyopharm Therapeutics Inc1
Rigel Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma13
Oligodendroglioma7
Glioblastoma6
Astrocytoma5
Brain Neoplasms5
Central Nervous System Neoplasms4
Neoplasms3
Biliary Tract Neoplasms2
Breast Neoplasms2
Gastrointestinal Stromal Tumors2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.